Related Experiment Video
Updated: Dec 14, 2025

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.9K
Tumor-induced rickets-osteomalacia: an enigma
Sandeep Kumar1, Ravikumar Shah1, Virendra Patil1
1Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, Mumbai, India.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|July 19, 2020
Summary
This case highlights tumor-induced osteomalacia (TIO) in a child, a rare cause of hypophosphatemic rickets. Early diagnosis and surgical removal of the phosphaturic mesenchymal tumor are crucial for recovery.
Area of Science:
- Pediatric Endocrinology
- Oncology
- Skeletal Dysplasias
Background:
- Tumor-induced osteomalacia (TIO) is a rare paraneoplastic condition characterized by renal phosphate wasting.
- It leads to severe hypophosphatemia and osteomalacia, often mimicking hereditary rickets.
Observation:
- A pediatric patient presented with a five-year history of rickets, initially diagnosed as hereditary hypophosphatemic rickets.
- Despite treatment with phosphorus and calcitriol, skeletal deformities progressed, leading to surgical interventions and iatrogenic tertiary hyperparathyroidism.
Findings:
- A large, 10.5 cm thoracic mass secreting fibroblast growth factor-23 was identified.
- Histopathology confirmed a phosphaturic mesenchymal tumor, mixed connective tissue variant, establishing the diagnosis of TIO.
- Surgical excision of the tumor resulted in significant postoperative improvement.
Implications:
- TIO should be considered in pediatric patients with refractory hypophosphatemic rickets, especially when an associated mass is detected.
- Timely diagnosis and surgical management of the underlying tumor can correct the metabolic bone disease.
- This case underscores the importance of a comprehensive diagnostic approach for rare endocrine and oncologic disorders in children.
Related Concept Videos
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Rous Sarcoma Virus (RSV) and Cancer
5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.9K
The Retinoblastoma Gene
4.5K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K
Bone Remodeling
40.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.0K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Osteoclasts in Bone Remodeling
3.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.6K

